Developer docs
API playgroundTry for free, no card

Search company profiles

Pharmia

Full company profile

uuid0005x6w

Namestring
Pharmia
Legal namestring
Pharmia Oy
Websiteurl
pharmia.fi
Company typeenum
Private
Founded yearint
1993
Descriptiontext

Pharmia Oy is a Finnish contract manufacturer specializing in food supplements and CE-marked medical devices, headquartered in Tuusula, Finland. Founded in 1993 as Finland's first contract manufacturer for pharmaceuticals and food supplements, the company has developed over 2,000 products for customers and maintains a portfolio of more than 400 raw materials. Pharmia operates a single-site facility and holds ISO 13485, FSSC 22000 and HACCP certifications, and was among the first companies in Finland to achieve EU MDR 2017/745 medical device compliance in December 2022.

The company generates revenue through B2B contract manufacturing services for brand owners, retailers and pharmaceutical companies, spanning product development, raw material sourcing, formulation, production, packaging, quality assurance and regulatory support. Dosage forms include tablets, capsules, powders, liquids and soft capsules. Operations are organized around an "idea to product" service concept with new product lead times of approximately four months and repeat orders delivered within three months on EXW terms. Pharmia also operates a branded catalog under the Pharmia Labs sub-brand covering probiotics, vitamins, minerals, beauty supplements and melatonin products for private label and white label deployment.

Pharmia was acquired by Italy-based Labomar Group, backed by private equity firm Charterhouse, in October 2025 and now operates as a subsidiary within that group, expanding its commercial reach beyond Finland into broader European B2B nutraceutical and medical device channels. Prior to the Labomar transaction, Finnish private equity firm CapMan had been the main owner since 2021. The company reported 51-100 employees and does not publicly disclose revenue.

Short descriptiontext

Pharmia Oy is a Finnish B2B contract manufacturer of food supplements and CE-marked medical devices, serving brand owners and pharmaceutical companies with product development, formulation, manufacturing, packaging and regulatory services from its Tuusula facility.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersTuusula, Finland
HQ citystring
Tuusula
HQ countrystring
Finland
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
contract manufacturing, food supplements, medical devices, private label, product development
Industry3 codes
PRIMARYHLAFALAE
Compounding Pharmacies (Sterile/Non-Sterile)
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services
SECONDARYHLAGAMAD
Specialty Pharma & Biologics Distribution (GDP-compliant)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Supply Chain, Logistics & Cold Chain for Life Sciences
SECONDARYHLAFALAC
Specialty Pharmacies (Complex/High-Cost Therapies)
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services
NAICS code2 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Medicinal and Botanical Manufacturing325411
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Nutraceutical Contract Manufacturing
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Contract Manufacturing Services
TypeOne Time License
Description

Pharmia generates revenue through contract manufacturing of food supplements and medical devices for brand owners. Services include product development, formulation, manufacturing, packaging, and quality assurance. Manufacturing lead time for new products is four months, with repeat orders delivered within three months. Minimum order quantities and pricing are negotiated per customer. Delivery terms typically EXW (Ex Works) where customer arranges pickup.

pharmia.fi
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Supply Chain, Operations, Technology or R&D, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Pharmia Labs
Description

Product brand for food supplements including probiotics, vitamins, minerals, and melatonin products.

pharmia.fi
Core offering1 text field

Pharmia is a Finnish contract manufacturer that produces food supplements and medical devices for brand owners. The company provides full-service manufacturing from product idea to finished, packaged, and quality-assured goods, covering formulation development, raw material sourcing, manufacturing, packaging, and quality control.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Delivery time for newly launched products is 4 months
+2 more records
Product overview1 text field

Pharmia is a Finnish contract manufacturer specializing in food supplements and medical devices. The company offers a portfolio of branded products under the Pharmia Labs sub-brand, including probiotic supplements (ProLab series), beauty supplements (Keratin, Collagen, TUKI), vitamins (C Liposomal, D Chew/B Drop/Drop/K2 Drop, Multivitamin for Vegans), minerals (Magnesium+B6, Calcium+D3, Iodine), and melatonin products (Long, Fast, General). The medical device portfolio includes nasal care products (NoseOil Nasal Spray series), common cold treatments (Pyroglutamate Nasal Spray, Zinc Lozenges, Zinc Throat Spray), Dry Mouth Spray, and Dimethicone-Lactase Capsules. Beyond product sales, Pharmia provides contract manufacturing services including product development, raw materials sourcing, manufacturing, packaging, and quality control—operating under a 'from idea to product' service concept.

Product and service7 records
1Contract Manufacturing Services
CategoryContract Manufacturing
2Product Development Services
CategoryProduct Development
3Raw Materials Sourcing
CategorySupply Chain Services
4Packaging Services
CategoryPackaging
5Quality Control
CategoryQuality Assurance
6Pharmia Labs Food Supplement Portfolio
CategoryFood Supplements
7Pharmia Labs Medical Device Portfolio
CategoryMedical Devices
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

German manufacturer of food supplements and natural health products, including contract manufacturing for brand owners. Comparable in product category (nutraceuticals), dosage forms (drops, tablets, liquids), and regulatory positioning (EU MDR/FSSC compliance).

TypeRegional player
Description

Australian pharmaceutical contract manufacturer with expanding European presence, producing supplements and OTC products for brand owners. Comparable in product category and CDMO business model, though operating primarily outside Pharmia's EU core geography.

TypeOthers
Description

European testing and CDMO services provider. Comparable as a contract development and manufacturing partner to pharma/consumer health companies, with overlap in quality testing, regulatory services, and supplement manufacturing capabilities across Europe.

4Swiss Caps
TypeDirect peer
Description

Swiss-based contract manufacturer specializing in capsules and softgels for pharma and nutraceutical customers. Comparable in capsule manufacturing technology and European B2B CDMO model serving supplement brand owners.

TypeBroad incumbent
Description

Global CDMO offering development and manufacturing services across biologics, softgels, oral solids, and specialty formats. Comparable in the softgel, oral solid, and consumer health CDMO segments relevant to Pharmia's supplement portfolio.

6Recipharm
TypeBroad incumbent
Description

Swedish-headquartered CDMO serving pharma and consumer health customers across multiple dosage forms. Comparable in B2B contract manufacturing model, EU regulatory footprint, and broad product category coverage, though Recipharm operates at significantly larger scale.

TypeOthers
Description

Global ingredient solutions and premix manufacturer serving supplement and functional food brands. Comparable as a B2B partner in the nutraceutical value chain with custom formulation and ingredient supply capabilities relevant to Pharmia's product development services.

TypeBroad incumbent
Description

German pharmaceutical contract manufacturer with strong European footprint across solid, semi-solid, and liquid dosage forms. Comparable as a broad European CDMO serving brand owners and pharma customers with multi-format manufacturing capabilities.

TypeDirect peer
Description

German pharmaceutical and supplement contract manufacturer offering brand development and manufacturing services. Comparable as a European mid-market CDMO with end-to-end product development capabilities for brand owners.

TypeDirect peer
Description

Italian CDMO specializing in food supplements, medical devices, and cosmetics. Pharmia is now a subsidiary of Labomar Group (acquired October 2025), making it the most directly comparable peer in product category, customer base (brand owners), and business model (contract manufacturing).

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Pharmia

Nutraceutical Contract Manufacturingpharmia.fi

Pharmia Oy is a Finnish B2B contract manufacturer of food supplements and CE-marked medical devices, serving brand owners and pharmaceutical companies with product development, formulation, manufacturing, packaging and regulatory services from its Tuusula facility.

What Pharmia does

Pharmia Oy is a Finnish contract manufacturer specializing in food supplements and CE-marked medical devices, headquartered in Tuusula, Finland. Founded in 1993 as Finland's first contract manufacturer for pharmaceuticals and food supplements, the company has developed over 2,000 products for customers and maintains a portfolio of more than 400 raw materials. Pharmia operates a single-site facility and holds ISO 13485, FSSC 22000 and HACCP certifications, and was among the first companies in Finland to achieve EU MDR 2017/745 medical device compliance in December 2022.

The company generates revenue through B2B contract manufacturing services for brand owners, retailers and pharmaceutical companies, spanning product development, raw material sourcing, formulation, production, packaging, quality assurance and regulatory support. Dosage forms include tablets, capsules, powders, liquids and soft capsules. Operations are organized around an "idea to product" service concept with new product lead times of approximately four months and repeat orders delivered within three months on EXW terms. Pharmia also operates a branded catalog under the Pharmia Labs sub-brand covering probiotics, vitamins, minerals, beauty supplements and melatonin products for private label and white label deployment.

Pharmia was acquired by Italy-based Labomar Group, backed by private equity firm Charterhouse, in October 2025 and now operates as a subsidiary within that group, expanding its commercial reach beyond Finland into broader European B2B nutraceutical and medical device channels. Prior to the Labomar transaction, Finnish private equity firm CapMan had been the main owner since 2021. The company reported 51-100 employees and does not publicly disclose revenue.

Pharmia firmographics

Firmographics
Name
Pharmia
Legal name
Pharmia Oy
Website
https://pharmia.fi
Company type
Private
Founded year
1993
Operating status
Operating
Headcount range
51–100 employees
Short description
Pharmia Oy is a Finnish B2B contract manufacturer of food supplements and CE-marked medical devices, serving brand owners and pharmaceutical companies with product development, formulation, manufacturing, packaging and regulatory services from its Tuusula facility.
Ownership category
akta.pro rank

Pharmia industry classification

Industry
Product category
Nutraceutical Contract Manufacturing
NAICS
Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAFALAE
Compounding Pharmacies (Sterile/Non-Sterile)
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services
SECONDARYHLAGAMAD
Specialty Pharma & Biologics Distribution (GDP-compliant)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Supply Chain, Logistics & Cold Chain for Life Sciences
SECONDARYHLAFALAC
Specialty Pharmacies (Complex/High-Cost Therapies)
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services

Keywords

  • Contract manufacturing
  • Food supplements
  • Medical devices
  • Private label
  • Product development

Where Pharmia is headquartered

Location

Headquarters

HQ city
Tuusula
HQ country
Finland
HQ region
Europe

Offices1 record

Markets served

Pharmia business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Supply Chain, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Contract Manufacturing Services: Pharmia generates revenue through contract manufacturing of food supplements and medical devices for brand owners. Services include product development, formulation, manufacturing, packaging, and quality assurance. Manufacturing lead time for new products is four months, with repeat orders delivered within three months. Minimum order quantities and pricing are negotiated per customer. Delivery terms typically EXW (Ex Works) where customer arranges pickup.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Pharmia product offering

Product offering

Core offering

Pharmia is a Finnish contract manufacturer that produces food supplements and medical devices for brand owners. The company provides full-service manufacturing from product idea to finished, packaged, and quality-assured goods, covering formulation development, raw material sourcing, manufacturing, packaging, and quality control.

Product overview

Pharmia is a Finnish contract manufacturer specializing in food supplements and medical devices. The company offers a portfolio of branded products under the Pharmia Labs sub-brand, including probiotic supplements (ProLab series), beauty supplements (Keratin, Collagen, TUKI), vitamins (C Liposomal, D Chew/B Drop/Drop/K2 Drop, Multivitamin for Vegans), minerals (Magnesium+B6, Calcium+D3, Iodine), and melatonin products (Long, Fast, General). The medical device portfolio includes nasal care products (NoseOil Nasal Spray series), common cold treatments (Pyroglutamate Nasal Spray, Zinc Lozenges, Zinc Throat Spray), Dry Mouth Spray, and Dimethicone-Lactase Capsules. Beyond product sales, Pharmia provides contract manufacturing services including product development, raw materials sourcing, manufacturing, packaging, and quality control—operating under a 'from idea to product' service concept.

Differentiator

Problem solved

Functional benefit

Brands

  • Pharmia Labs: Product brand for food supplements including probiotics, vitamins, minerals, and melatonin products.

Products and services

  • Contract Manufacturing Services
  • Product Development Services
  • Raw Materials Sourcing
  • Packaging Services
  • Quality Control
  • Pharmia Labs Food Supplement Portfolio
  • Pharmia Labs Medical Device Portfolio

Quantifiable outcome

  • Delivery time for newly launched products is 4 months
  • +2 more outcomes

Companies that use Pharmia

Customer profile

Segments3 records

Ideal customer profiles1 record

Pharmia technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Pharmia partnerships and signals

Strategic signal

Scale indicators5 records

Recent moves10 records

Expansion highlights4 records

Pharmia competitors and assessment

Company assessment

Direct peers

  • Salus Haus: German manufacturer of food supplements and natural health products, including contract manufacturing for brand owners. Comparable in product category (nutraceuticals), dosage forms (drops, tablets, liquids), and regulatory positioning (EU MDR/FSSC compliance).
  • Swiss Caps: Swiss-based contract manufacturer specializing in capsules and softgels for pharma and nutraceutical customers. Comparable in capsule manufacturing technology and European B2B CDMO model serving supplement brand owners.
  • Hermes Arzneimittel: German pharmaceutical and supplement contract manufacturer offering brand development and manufacturing services. Comparable as a European mid-market CDMO with end-to-end product development capabilities for brand owners.
  • Labomar Group: Italian CDMO specializing in food supplements, medical devices, and cosmetics. Pharmia is now a subsidiary of Labomar Group (acquired October 2025), making it the most directly comparable peer in product category, customer base (brand owners), and business model (contract manufacturing).

Regional players

  • Bioglan: Australian pharmaceutical contract manufacturer with expanding European presence, producing supplements and OTC products for brand owners. Comparable in product category and CDMO business model, though operating primarily outside Pharmia's EU core geography.

Others

  • Eurofins CDMO: European testing and CDMO services provider. Comparable as a contract development and manufacturing partner to pharma/consumer health companies, with overlap in quality testing, regulatory services, and supplement manufacturing capabilities across Europe.
  • Glanbia Nutritionals: Global ingredient solutions and premix manufacturer serving supplement and functional food brands. Comparable as a B2B partner in the nutraceutical value chain with custom formulation and ingredient supply capabilities relevant to Pharmia's product development services.

Broad incumbents

  • Catalent: Global CDMO offering development and manufacturing services across biologics, softgels, oral solids, and specialty formats. Comparable in the softgel, oral solid, and consumer health CDMO segments relevant to Pharmia's supplement portfolio.
  • Recipharm: Swedish-headquartered CDMO serving pharma and consumer health customers across multiple dosage forms. Comparable in B2B contract manufacturing model, EU regulatory footprint, and broad product category coverage, though Recipharm operates at significantly larger scale.
  • Aenova Group: German pharmaceutical contract manufacturer with strong European footprint across solid, semi-solid, and liquid dosage forms. Comparable as a broad European CDMO serving brand owners and pharma customers with multi-format manufacturing capabilities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Pharmia social profiles

Digital presence

Pharmia compliance and trust

Trust signal

Compliance4 records

Pharmia financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Pharmia leadership team

Management profile

Number of profiles

Profiles2 records

Pharmia funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Pharmia M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharmia

What does Pharmia do?

Pharmia is a Finnish contract manufacturer that produces food supplements and medical devices for brand owners. The company provides full-service manufacturing from product idea to finished, packaged, and quality-assured goods, covering formulation development, raw material sourcing, manufacturing, packaging, and quality control.

Is Pharmia a public or private company?

Pharmia is a private company. It is classified as corporate owned and is currently operating.

When was Pharmia founded?

Pharmia was founded in 1993. It employs 51 to 100 people.

Where is Pharmia based?

Pharmia is headquartered in Tuusula, Finland, in the Europe region.

How does Pharmia make money?

One revenue line is on record: contract Manufacturing Services.

Who are Pharmia's main competitors?

Direct peers on record are Salus Haus, Swiss Caps, Hermes Arzneimittel and Labomar Group. Bioglan is listed as a regional player. Others are Eurofins CDMO and Glanbia Nutritionals. Broad incumbents are Catalent, Recipharm and Aenova Group.

Does Pharmia have an API?

No public API is recorded for Pharmia.

What industry is Pharmia in?

Pharmia's product category is Nutraceutical Contract Manufacturing. Its primary akta.pro industry code is HLAFALAE, Compounding Pharmacies (Sterile/Non-Sterile), with a secondary code of HLAGAMAD, Specialty Pharma & Biologics Distribution (GDP-compliant). Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Empresas de Capital Riesgo en EspaAlantra advises CapMan Buyout on the sale of Pharmia Holding Oy to Labomar S.p.A., a Charterhouse portfolio companyAlantra served as financial advisor to CapMan Buyout on the sale of Pharmia Holding Oy to Labomar S.p.A., with the transaction described as one of the largest in the Nordic VMS (vitamins, minerals, supplements) CDMO space in recent years. Pharmia, Finland's leading contract development and manufacturing organization specializing in food supplements, probiotics, and medical devices, was acquired by Italy-based Labomar, a full-service CDMO backed by Charterhouse Capital Partners. The deal marks a significant step in Labomar's expansion into Northern Europe and represents Alantra's fifth transaction in the European VMS CDMO sector in nine months.CapmanCapMan Buyout exits Pharmia to LabomarCapMan Buyout has sold Pharmia to Labomar in a strategic exit, with the transaction finalized in October 2025. Pharmia, based in Finland, specializes in manufacturing dietary supplements and medical devices, and has been growing in the Nordics.PharmiaPharmia Oy joins Labomar GroupPharmia Oy, a Finnish health and well-being company, has been acquired by the Italian Labomar Group. Pharmia will continue operating under its own name with its current team as part of Labomar Group's organization. The acquisition is aimed at strengthening innovation and growth in food supplements, medical devices, cosmetics, and specialized nutrition products.EuropaWireLabomar acquires Finland-based Pharmia Holding Oy from CapMan to strengthen European probiotics and medical devices portfolioCapMan Buyout has completed the sale of Finnish contract manufacturer Pharmia Holding Oy to Italy-based Labomar, a European health and wellness group backed by Charterhouse Capital Partners. Pharmia, which generates approximately €20 million in annual revenues and employs 85 people, has grown into the leading Nordic contract manufacturer of dietary supplements and medical devices since CapMan's 2021 investment. The acquisition strengthens Labomar's presence in the Nordics and consolidates its position in the probiotics sector, with combined operations now spanning Italy, Spain, Canada, and Finland.UnquoteCapMan to acquire PharmiaCapMan acquired a majority stake in Finnish food supplement and medical devices firm Pharmia alongside its owner family. The deal is the second investment from CapMan Buyout XI, which has a €250m target. The transaction is expected to close by the end of March 2021.news.cision.comCapMan Buyout invests in food supplement and medical device specialist PharmiaCapMan Buyout acquired a majority stake in Finnish food supplement and medical device specialist Pharmia, with the family retaining a significant share. The transaction, expected to close by end of March 2021, is the second investment of CapMan's XI fund. CapMan aims to accelerate growth organically and through acquisitions.